Education and Knowledge in Pharmacogenomics: Still a Challenge?

Jyothsna Giri, Timothy B. Curry, Christine M. Formea, Wayne T. Nicholson, Carolyn R. Rohrer Vitek

Research output: Contribution to journalComment/debatepeer-review

18 Scopus citations


A number of barriers exist for adoption of pharmacogenomics into practice. Physicians, pharmacists, and nurses report limited knowledge about pharmacogenomics and its use in patient care. Lack of pharmacogenomics education curricula as part of professional schools or postgraduate training programs has been reported as a potential cause. Understanding pharmacogenomics is further complicated by a complex and nonstandard lexicon, limited medication guidelines, rapidly changing evidence, and insufficient awareness of test availability and utility.

Original languageEnglish (US)
Pages (from-to)752-755
Number of pages4
JournalClinical pharmacology and therapeutics
Issue number5
StatePublished - May 2018

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Education and Knowledge in Pharmacogenomics: Still a Challenge?'. Together they form a unique fingerprint.

Cite this